Kefeng Yang1, Cheng Chen2, John Brockman3, James M Shikany4, Ka He5. 1. Department of Nutrition, Xin Hua Hospital Affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, China. 2. Department of Obstetrics and Gynecology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. 3. Columbia Research Reactor, University of Missouri, Columbia, MO, USA. 4. Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. 5. Department of Obstetrics and Gynecology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. Electronic address: kk3399@cumc.columbia.edu.
Abstract
BACKGROUND: It is unclear whether arsenic exerts adverse health effects on the kidney at low- and moderate- levels of exposure. We prospectively examined toenail arsenic concentrations measured during young adulthood in relation to incidence of chronic kidney disease (CKD) in midlife. METHODS: A total of 3768 participants (53 % female and 48 % blacks) in the Coronary Artery Risk Development in Young Adults (CARDIA) study were included. Arsenic concentration in toenail clippings was assessed by using inductively coupled plasma mass spectrometry at CARDIA exam year 2. Incident CKD was identified if having estimated glomerular filtration rate <60 mL/min per 1.73 m² or albuminuria >30 mg/g. The association between toenail arsenic levels and CKD incidence over a mean of 24 years of follow-up was examined using multivariable-adjusted Cox proportional hazards models. RESULTS: After controlling for potential confounders, including demographics, socioeconomics, lifestyle factors, clinical measurements of blood pressure, lipids, and glucose, and medical history, arsenic exposure measured in toenails was not associated with CKD incidence (quintile 5 versus quintile 1: hazard ratio = 1.04, 95 % confidence interval = 0.78-1.40, P for trend = 0.38). CONCLUSION: This longitudinal study does not support the hypothesis that low- and moderate- levels of arsenic exposure are associated with elevated incidence of CKD in the US general population. Further studies are need to investigate species of arsenic biomarkers in relation to nephrotoxicity.
BACKGROUND: It is unclear whether arsenic exerts adverse health effects on the kidney at low- and moderate- levels of exposure. We prospectively examined toenail arsenic concentrations measured during young adulthood in relation to incidence of chronic kidney disease (CKD) in midlife. METHODS: A total of 3768 participants (53 % female and 48 % blacks) in the Coronary Artery Risk Development in Young Adults (CARDIA) study were included. Arsenic concentration in toenail clippings was assessed by using inductively coupled plasma mass spectrometry at CARDIA exam year 2. Incident CKD was identified if having estimated glomerular filtration rate <60 mL/min per 1.73 m² or albuminuria >30 mg/g. The association between toenail arsenic levels and CKD incidence over a mean of 24 years of follow-up was examined using multivariable-adjusted Cox proportional hazards models. RESULTS: After controlling for potential confounders, including demographics, socioeconomics, lifestyle factors, clinical measurements of blood pressure, lipids, and glucose, and medical history, arsenic exposure measured in toenails was not associated with CKD incidence (quintile 5 versus quintile 1: hazard ratio = 1.04, 95 % confidence interval = 0.78-1.40, P for trend = 0.38). CONCLUSION: This longitudinal study does not support the hypothesis that low- and moderate- levels of arsenic exposure are associated with elevated incidence of CKD in the US general population. Further studies are need to investigate species of arsenic biomarkers in relation to nephrotoxicity.
Authors: Kefeng Yang; Pengcheng Xun; Mercedes Carnethon; April P Carson; Liping Lu; Jie Zhu; Ka He Journal: Environ Res Date: 2019-01-25 Impact factor: 6.498
Authors: Rebecca Shelley; Nam-Soo Kim; Patrick J Parsons; Byung-Kook Lee; Jacqueline Agnew; Bernard G Jaar; Amy J Steuerwald; Genevieve Matanoski; Jeffrey Fadrowski; Brian S Schwartz; Andrew C Todd; David Simon; Virginia M Weaver Journal: J Expo Sci Environ Epidemiol Date: 2013-04-17 Impact factor: 5.563
Authors: D R S Middleton; M J Watts; E M Hamilton; T Fletcher; G S Leonardi; R M Close; K S Exley; H Crabbe; D A Polya Journal: Environ Sci Process Impacts Date: 2016-04-27 Impact factor: 4.238
Authors: G D Friedman; G R Cutter; R P Donahue; G H Hughes; S B Hulley; D R Jacobs; K Liu; P J Savage Journal: J Clin Epidemiol Date: 1988 Impact factor: 6.437
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Muhammad Shahid; Nabeel Khan Niazi; Camille Dumat; Ravi Naidu; Sana Khalid; Mohammad Mahmudur Rahman; Irshad Bibi Journal: Environ Pollut Date: 2018-06-28 Impact factor: 8.071
Authors: Rakhi P Naik; Vimal K Derebail; Morgan E Grams; Nora Franceschini; Paul L Auer; Gina M Peloso; Bessie A Young; Guillaume Lettre; Carmen A Peralta; Ronit Katz; Hyacinth I Hyacinth; Rakale C Quarells; Megan L Grove; Alexander G Bick; Pierre Fontanillas; Stephen S Rich; Joshua D Smith; Eric Boerwinkle; Wayne D Rosamond; Kaoru Ito; Sophie Lanzkron; Josef Coresh; Adolfo Correa; Gloria E Sarto; Nigel S Key; David R Jacobs; Sekar Kathiresan; Kirsten Bibbins-Domingo; Abhijit V Kshirsagar; James G Wilson; Alexander P Reiner Journal: JAMA Date: 2014-11-26 Impact factor: 157.335